Skip to content
DataLookout
Menu

NCT07927452

Anatomic Versus Nonanatomic Liver Resection After Conversion Therapy for Hepatocellular Carcinoma

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

2-year recurrence-free survival (RFS) rate
Timeframe: From enrollment to the end of treatment at 2 years

Secondary (3)

Recurrence-free survival (RFS)
Overall survival (OS)
Time to recurrence (TTR)

Arms and interventions

Anatomic Liver Resection (ALR)

Participants with HCC who undergo anatomic liver resection after conversion therapy.

Non-anatomic Liver Resection (NALR)

Participants with HCC who undergo nonanatomic liver resection after conversion therapy

Sites

1 site in 1 country

  • Sun Yat-sen University Cancer CenterGuangzhou, Guangdong, China